Company Ticker News February 15, 2022atai Life Sciences to Participate in Upcoming February Investor Conference 0 0 Share
Press Release January 12, 2022atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program 0 0 Share
Press Release November 30, 2021Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways 0 0 Share
Company Ticker News November 8, 2021atai Life Sciences to Host Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Business Update 0 0 Share
Company Ticker News November 6, 2021atai Life Sciences to Participate in Upcoming November Investor Conferences 0 0 Share
Company Ticker News November 3, 2021This Psychedelics Stock Was Up More Than 20% Last Week, Outperforming Tesla, Nvidia and GameStop 0 0 Share
Company Ticker News October 12, 2021What Is Precision Psychiatry? Biotech Company Leverages New Approach To Mental Health Disorders 0 0 Share
Company Ticker News September 15, 2021Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine 0 0 Share
